GREENVILLE, SOUTH CAROLINA CCOP

南卡罗来纳州格林维尔CCOP的长期目标是 包括： 1)统一和资助NCI支持的癌症控制和癌症试验 在南卡罗来纳州格林维尔县及周边地区； 2)支持肿瘤学临床研究的发展和扩大 格林维尔地区； 3)扩大初级保健提供者和其他 癌症预防和癌症控制方面的专家正在进行试验； 4)将最新的研究成果传递给服务的居民 面积； 5)增加NCI支持的临床试验的可用性 该地区有相当多的少数民族和不应得的人口。 首先：南卡罗来纳州格林维尔的CCOP将把两个CCOP 和兽类癌症预防试验已经到位，通过建立 癌症治疗中心资助的数据管理办公室 格林维尔纪念医院，格林维尔医院的一个组成部分 系统(GHS)。如果这两个CCOP是1993年历年的CCOP， SWOG、NSABP和RTOG的治疗收益应该是97 病人和98个学分；癌症控制的应计费用应该是 43名患者和43.1个学分。如果谷歌是一个研究基地，一个 另外6名患者将被添加到治疗应计费用中(表8A和 8C)。第二：CCOP将满足日益增长的数据管理需求 在一个外科、妇科、放射和内科 肿瘤学家已经致力于癌症临床研究 美国国家情报局。肿瘤内科医生的人数从5人增加到7人， 妇科肿瘤医生的人数从0人增加到2人 1994年。同时，参与临床的适应症 试验和临床试验的数量正在增加。特别是， 增加肺癌(SWOG 9221)和耳鼻喉科(SWOG 9043)化学预防 预计将进行研究。第三和第四项：癌症控制计划 将延伸到肿瘤学家之外，并将征募 对初级保健和其他医生的期望。例如, 结直肠癌的化学预防和饮食试验(SWOG 9041)， 妇科和空气消化系统癌症将会接触到那些 过去只参与过癌症研究的外围领域。这个 向社区提供这些试验将是一种使用的机制 由合作社推广全面的癌症控制意识和教育 社区。增加维克森林作为研究基地将使 使用以前无法获得的与以下相关的癌症控制研究 乳腺癌和结肠癌。第五：几乎所有的肿瘤学 格林维尔县的护理是在组件和附属站点提供的 CCOP，允许扩大对NCI临床试验的访问 少数人和不应得的农村人口已经在这些 网站。

The Greenville, South Carolina CCOP has long-term objectives that include: 1) Unifying and funding NCI-supported cancer control and cancer trials in Greenville County, South Carolina, and the surrounding area; 2) Supporting growth and expansion of oncology clinical research in the Greenville area; 3) Expanding the involvement of primary care providers and other specialists in cancer prevention and cancer control in trials; trials; 4) Transferring the latest research finding to residents of the service area; 5) increasing the availability of NCI-supported clinical trials to the substantial minority and undeserved populations in the area. First: the Greenville, South Carolina CCOP will pull together two CCOP's and the beast Cancer Prevention Trial already in place by establishing a funded data management office at the Cancer Treatment Center at Greenville Memorial Hospital, a component of the Greenville Hospital system (GHS). If these two CCOPs have been a CCOP in calendar year 1993, the therapy accruals from SWOG, NSABP, and RTOG would have been 97 patients and 98 credits; and the cancer control accruals would have been 43 patients and 43.1 credits. If the GOG were a research base, an additional 6 patients would be added to therapy accruals (Tables 8A and 8C). Second: the CCOP will serve the increased need for data management in a community where surgical, gynecological, radiation, and medical oncologist are already committed to cancer clinical research through the NCI. The number of medical oncologist have increased from five to seven, and the number of gynecologic oncologist has increased from zero to two in 1994. At the same time, the indications for participation in clinical trials and the numbers of clinical trials are increasing. In particular, increased lung cancer (SWOG 9221) and ENT (SWOG 9043) chemoprevention studies are anticipated. Third and fourth: cancer control programs through the COOP will extend beyond the oncologist and will enlist the anticipation of primary care and other physicians. For example, chemoprevention and dietary trials for colorectal (SWOG 9041), gynecologic, and aerodigestive cancers will reach out to physicians who have been only peripherally involved in cancer research in the past. The availability of these trials to the community will be a mechanism used by the COOP to promote overall cancer control awareness and education in the community. The addition of Wake Forest as a research base will allow the use of previously unavailable cancer control studies related to breast cancer and colon cancer. Fifth: Virtually all of the oncology care in Greenville County is provided at the component and affiliate site of the CCOP, allowing expanded access to NCI clinical trials for the minority and undeserved rural populations who are already seen at these sites.